MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
Peilong Li(Shandong University), Chuanxin Wang(Jilin University)
Cited by 249
Related Papers
MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin
|PLoS ONE|2015|57
Aberrant expression of circulating Th17, Th1 and Tc1 cells in patients with active and inactive ulcerative colitis
|International Journal of Molecular Medicine|2013|43
Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway
|International Journal of Molecular Medicine|2013|20
Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28
|British Journal of Cancer|2023|20
Silencing of PRDX2 Inhibits the Proliferation and Invasion of Non‐Small Cell Lung Cancer Cells
|BioMed Research International|2020|13